Kerry Lane Hendershot, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Quaker Ave, Lubbock, TX 79424 Phone: 806-725-9653 Fax: 806-725-9650 |
Patricia Cumming Hood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6809 Slide Rd Ste J, Lubbock, TX 79424 Phone: 806-794-9378 Fax: 806-799-0691 |
Dr. Kompal Parmar, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9812 Slide Rd, Lubbock, TX 79424 Phone: 806-725-8444 Fax: 806-725-8443 |
Dr. Aaron Alexander Thomas, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3601 4th St Stop 8143, Lubbock, TX 79430 Phone: 806-743-7200 |
Raymond Harvey Collier, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Quaker Ave, Lubbock, TX 79424 Phone: 806-725-9563 Fax: 806-725-9500 |
Emily A Deeb, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |
Christie Chantal Mcnair, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-9700 |
Porntip Chungchansat, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 416 Frankford, Lubbock, TX 79416 Phone: 806-725-5410 Fax: 806-792-7157 |
Dr. Craig Barker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6205 43rd St, Lubbock, TX 79407 Phone: 806-749-2263 Fax: 806-749-2264 |
Felix Morales, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St, Ms 8143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 |
Jack W. Dyer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 |
Harold R. Capps, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Texas Tech University Student Health Clinic, Flint And Main, Texas Tech University Campus, Lubbock, TX 79430 Phone: 806-743-2860 Fax: 806-743-2122 |
Dr. Emily Michelle Capt, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3601 4th St, Lubbock, TX 79430 Phone: 806-743-1000 |
Steven Michael Crow, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Quaker Ave, Lubbock, TX 79424 Phone: 806-797-4422 Fax: 806-799-1817 |
Dr. Robert L Ordonez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3709 22nd Pl, Suite B, Lubbock, TX 79410 Phone: 806-797-2616 Fax: 806-791-3122 |
Dr. Heather D. Blaylock, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 N Frankford Ave, Lubbock, TX 79416 Phone: 806-725-5840 Fax: 806-723-6156 |
Abdul B Khan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5520 4th St, Lubbock, TX 79416 Phone: 806-761-0475 |
Dr. Paul Joseph Maslanka Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St, Stop 8143, Lubbock, TX 79430 Phone: 806-743-2757 |
Dr. Ann Catherine Hughes Bass, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5130 82nd St, Lubbock, TX 79424 Phone: 806-761-0275 Fax: 806-761-0276 |
Dr. Jennifer E Zuccarelli, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7008 Salem Ave # 117, Lubbock, TX 79424 Phone: 800-924-7811 Fax: 877-349-1868 |
News Archive
Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.
There is evidence that selective serotonin reuptake inhibitor antidepressants can promote neuronal cell proliferation and enhance neuroplasticity both in vitro and in vivo.
Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that new data highlighting fidaxomicin's (OPT-80) lower CDI recurrence rates and reduced risk of vancomycin-resistant enterococci (VRE) acquisition from Optimer's North American phase 3 study were presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
› Verified 3 days ago